$ Value
$0
Shares
109,105
Price
$0
Filed
Mar 3
Insider
Name
Hopman Mark
Title
Chief Commercial Officer
CIK
0002048497
Roles
Transaction Details
Transaction Date
2026-02-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
140,320
Footnotes
Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. | The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. | The weighted average sale price for the transaction reported was $12.3616 and the range of prices were between $12.20 and $12.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026.
Filing Info
Hopman Mark's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-04 | BBNX | ▼ | $4K |
| 2026-03-02 | BBNX | ▼ | $10K |
| 2026-02-27 | BBNX | A | $0 |
| 2026-02-27 | BBNX | A | $0 |
| 2026-02-27 | BBNX | A | $0 |
| 2025-12-04 | BBNX | ▼ | $63K |
| 2025-12-02 | BBNX | ▼ | $25K |
| 2025-09-05 | BBNX | M | $58K |
| 2025-09-05 | BBNX | ▼ | $235K |
| 2025-09-05 | BBNX | M | $0 |
Other Insiders at BBNX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hopman Mark
Chief Commercial Officer
|
— | $103K | 2026-03-04 |
|
Mensinger Mike
Chief Product Officer
|
— | $13K | 2026-03-02 |
|
Feider Stephen
Chief Financial Officer
|
— | $18K | 2026-03-02 |
|
Saint Sean
President & CEO
|
— | $42K | 2026-03-02 |
|
Russell Steven Jon
Chief Medical Officer
|
— | $43K | 2026-03-02 |